Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To compare the penetration of three different NSAIDs.

• Phase: Phase 4

Details

• Lead Sponsor: Innovative Medical
• Treatments: Bromfenac; Ketorolac; Nepafenac

Criteria

Inclusion Criteria:

• Males or females scheduled to undergo Vitrectomy surgery

• Likely to complete all study visits and able to provide informed consent

• Visual potential of 20/25 or better

Exclusion Criteria:

• Known contraindications to any study medication or ingredients

• Active ocular diseases or uncontrolled systemic disease

• Active ocular allergies